OR
AMED

Olympiad Research’s Amedisys AMED Stock Holding History

Olympiad Research’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,865
Closed -$577K – 210
2025
Q2 		$577K Hold
5,865
– – 0.94% 12
2025
Q1 		$543K Hold
5,865
– – 0.63% 21
2024
Q4 		$532K Sell
5,865
-15,077
-72% -$1.38M 0.55% 31
2024
Q3 		$2.02M Hold
20,942
– – 1.31% 8
2024
Q2 		$1.92M Hold
20,942
– – 1.41% 10
2024
Q1 		$1.93M Hold
20,942
– – 1.27% 14
2023
Q4 		$1.99M Buy
20,942
+4,974
+31% +$465K 1.57% 6
2023
Q3 		$1.49M Buy
15,968
+7,777
+95% +$719K 1.46% 6
2023
Q2 		$749K Buy
+8,191
New +$672K 0.74% 22
2020
Q4 		– Sell
-1,396
Closed -$330K – 126
2020
Q3 		$330K Buy
+1,396
New +$317K 0.17% 138

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Olympiad Research's AMED Position: Q3 2025 in Review

Olympiad Research sold out of Amedisys (AMED) in Q3 2025, closing a stake of 5,865 shares — an estimated $577K sold.

Olympiad Research first reported a position in AMED in Q3 2020 and held it in 10 quarters. The position peaked at $2.02M in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Olympiad Research reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Olympiad Research sold 5,865 Amedisys shares in Q3 2025, an estimated $577K.
  • Olympiad Research first reported a position in Amedisys in Q3 2020 and held it in 10 quarters.
  • Olympiad Research's Amedisys position peaked at $2.02M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Olympiad Research's 13F filing for Q3 2025, filed 30 Oct 2025.